Fulltext

Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes

Shahrizaila N 1 , Kokubun N 1 , Sawai S 1 , Umapathi T 1 , Chan YC 1 , Kuwabara S 1 Show all authors , Hirata K 1 , Yuki N 2

Affiliations 

  • 1 From the Faculty of Medicine (N.S.), University of Malaya, Kuala Lumpur, Malaysia; Dokkyo Medical University (N.K., K.H.), Tochigi, Japan; Graduate School of Medicine (S.S., S.K.), Chiba University, Japan; National Neurosciences Institute (T.U.), Singapore; and National University Singapore (Y.-C.C., N.Y.), Singapore
  • 2 From the Faculty of Medicine (N.S.), University of Malaya, Kuala Lumpur, Malaysia; Dokkyo Medical University (N.K., K.H.), Tochigi, Japan; Graduate School of Medicine (S.S., S.K.), Chiba University, Japan; National Neurosciences Institute (T.U.), Singapore; and National University Singapore (Y.-C.C., N.Y.), Singapore. mdcyuki@nus.edu.sg
Neurology, 2014 Jul 8;83(2):118-24.
PMID: 24920848 DOI: 10.1212/WNL.0000000000000577

Abstract

To comprehensively investigate the relationship between antibodies to single glycolipids and their complexes and Guillain-Barré syndrome subtypes and clinical features.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications